U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07186309) titled 'A Study of a Test for Postpartum Depression at Home' on Sept. 15.
Brief Summary: The study will seek to prospectively validate the Enlighten Device for prediction of PPD by examining true/false positive and negative rates of the test using PPD outcomes collected through 3 months postpartum; compare the accuracy of biomarkers and algorithm in determining risk for PPD in blood compared to saliva; determine the utility of a week 6 sample collection in identifying women who are currently experiencing PPD thus bringing them to clinical attention.
Our population will consist of pregnant women aged 18 and older up to 33 weeks of gestatio...